Biomagnetics Diagnostics Corp. Retains Emerging Growth Research, LLP for Public and Investor Relations
ORANGEVALE, Calif.-(Business Wire)-September 14, 2009 - Biomagnetics Diagnostics Corp., a producer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis, and malaria detection, today announced it has retained Emerging Growth Research, LLP to manage its public relations and investor relations programs. Emerging Growth Research specializes in small market capitalization companies in the technology and biotechnology sectors.
“We are very excited to be working with Joe Noel and Emerging Growth Research, LLP. The firm's track record in assisting smaller sized emerging companies in getting its story out to investors, vendors, and the public is impressive,” commented Clayton Hardman, CEO of Biomagnetics Diagnostic, Corp. “We are preparing to enter some very exciting areas, especially relating to malaria and bovine tuberculosis testing. We plan on launching some of the most innovative technologies within this market space and we believe Emerging Growth Research will be instrumental in our investor, capital formation, and vendor-related efforts. We look forward to working with them over the coming year.”
According to the World Health Organization some 3.2 billion people, or about half the world's population, is at risk of malaria transmission in 107 countries and territories worldwide. While there are between 350 million and 500 million new cases of malaria each year, there are very few reliable and field deployable diagnostic tools available. In the case of malaria, early detection substantially improves treatability and survivability. TB (tuberculosis) is the second leading cause of death from infectious disease worldwide. Bovine TB is a growing problem throughout the world with an estimated 1.3 billion cattle at risk. In the United States where the cattle industry is valued at $60 billion annually, the use of existing diagnostic tests currently add $5.00 to $15.00 on average per head to the cattle industry's costs. Field deployable Integrated Optical Biosensor Systems (IBOS), such as those Biomagnetics Diagnostics plans to introduce to the market, hold the promise to significantly speed diagnostic testing in the field which would meaningfully lower costs.
About Biomagnetics Diagnostics Corp.
Biomagnetics Diagnostics Corporation is an advanced medical device and biotechnology company. The Company’s revolutionary diagnostic systems, which are based on advanced magnetics, test for any viral or bacterial disease using any body fluid. The Company's technology allows laboratories to perform far more tests in the same amount of time it takes to do a single test. The HTS-MTP platform is designed to detect the actual virus and viral load in body fluids and not just simply screen for the presence of viral antibodies. More information on Biomagnetics Diagnostics Corp. can be seen at www.BiomagneticsBMGP.com.
 |
 |
 |
|
||
 |
|
 |
|
||
Search Our News Using Google Search
Can't find what you want? Try using Google:
